[nyschp.dop] Re: Daraprim (Vacation) (Out of Office) (Out of Office Sept. 21 to Oct.7, 2015)

  • From: "NICHOLAS PANTALEO" <NPANTALE@xxxxxxxx>
  • To: "nyschp.dop@xxxxxxxxxxxxx" <nyschp.dop@xxxxxxxxxxxxx>
  • Date: Tue, 22 Sep 2015 13:20:18 -0400

I will be out of the office until October 7, 2015. Kindly call Louis Cosenza
(#6052) for assistance. Thank you.

N. Pantaleo

"Michael Blumenfeld" <Michael.Blumenfeld@xxxxxxxxxxxxxxxxxxx> 09/22/15
13:19 >>>

I will be out of the office beginning Tuesday afternoon, September 22, 2015
returning Thursday, September 24. 2015 and will have no access to email and
phone service during that time period. If you seek an immediate response,
please contact Alejandra Hernandez at 1-212-562-6504 and she will connect you
with Dr. Beverly Mogran, Assocate Director, or the appropriate Pharmacy
specialty Assistant Director or manager. During off hours and weekends, please
contact the Pharmacy Manager on-call.

Thank you.

michael


Michael Blumenfeld
Director of Pharmacy Services
Bellevue Hospital Center
Office Phone: 1-212-562-6504
Fax: 1-212-562-2936
Personal Cell: 1-845-545-1220

Bellevue's Pharmacy charts the course to optimal pharmaceutical care for the
safety & welfare of our patients.

"Michael Thomas" <THOMASMIC@xxxxxxxxxx> 09/22/15 13:19 >>>

I will be out of the office from Wednesday 7/15/15 and will return on Monday
8/3/15. In my absence, the following staff can be contacted:
Ms. Kim - Inpatient, Narcotics and Pyxis x3564 or x5864
Jacek Wasiak - Outpatient Pharmacy x5630, x5631
Frank Piacenti - Clinical Pharmacy Issues x5524
Cecilia Obijuru - Patient Indigent Programs x6351
Louis-Marie Desroches - IV Preparation x4950, x3911
Laure Daymard - Chemotherapy x1476,
Ly-Pha Tang - Medication Cart Exchanges, Bar Code Issues, x4355

Michael G. Thomas, PharmD, M.S.
Director, Pharmacy Services
Lincoln Medical & Mental Health Center
718-579-6267
thomasmic@xxxxxxxxxx

"Narayanaswamy, Sudha" <SNarayanaswamy@xxxxxxxxx> 09/21/15 16:08 >>>

In light of recent developments, has your hospital's P&T or ID committee
considered reviewing alternatives to pyrimethamine (Daraprim) for toxoplasmosis?

Sincerely,
Sudha
--
Sudha Narayanaswamy, PharmD, BCPP, CGP
Vice President, Clinical Pharmacy Program
GNYHA Services, Inc. | 555 W. 57th Street, 11th Floor | New York, NY 10019
o: 212-258-5376 | f: 212-541-9032 | E-mail:
snarayanaswamy@xxxxxxxxx<mailto:snarayanaswamy@xxxxxxxxx>
Website: Http://pharmacy.gnyhaservices.com<http://pharmacy.gnyhaservices.com/>












CONFIDENTIALITY NOTICE: This electronic, facsimile, or written communication,
including any attachments to it, may contain confidential information or
protected health information subject to privacy regulations such as the Health
Insurance Portability and Accountability Act of 1996 (HIPAA). This transmission
is intended only for the use of the named recipients. If you are not the
intended recipient, or a person responsible for delivering it to the intended
recipient, you are hereby notified that any disclosure, copying, distribution
or use of any of the information contained in this transmission is STRICTLY
PROHIBITED. If you have received this transmission in error, please immediately
notify me by reply e-mail and destroy the original transmission in its entirety
without saving it in any manner.

Other related posts:

  • » [nyschp.dop] Re: Daraprim (Vacation) (Out of Office) (Out of Office Sept. 21 to Oct.7, 2015) - NICHOLAS PANTALEO